Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Urologic Oncology
|
July 20, 2016
Accuracy of urethral frozen section during radical cystectomy for bladder cancer
Max Kates, Mark W Ball, Meera R Chappidi, et al.
The Prostate
|
June 10, 2023
Prostate cancer genetic alterations in Hispanic men
Camilo Arenas-Gallo, Stephen Rhodes, Jorge A Garcia, et al.
Oncotarget
|
September 9, 2017
Lack of association between the pancreatitis risk allele CEL-HYB and pancreatic cancer
Koji Shindo, Jun Yu, Masaya Suenaga, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
August 22, 2017
High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer
Max Kates, Meera R Chappidi, Aaron Brant, et al.
Gut
|
July 20, 2016
Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms
Jun Yu, Yoshihiko Sadakari, Koji Shindo, et al.
JNCI Cancer Spectrum
|
October 5, 2023
Individual-level home values and cancer mortality in a statewide registry
Alec Zhu, Stephen Rhodes, Weichuan Dong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 8, 2014
KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound
James R Eshleman, Alexis L Norris, Yoshihiko Sadakari, et al.
European Urology Oncology
|
May 26, 2023
Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis
Ilon C Weinstein, Xian Wu, Alexander Hill, et al.
European Urology
|
August 21, 2020
Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Russell E N Becker, Alexa R Meyer, Aaron Brant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2019
Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
Max Kates, Andres Matoso, Woonyoung Choi, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Urologic Oncology
|
July 20, 2016
Accuracy of urethral frozen section during radical cystectomy for bladder cancer
Max Kates, Mark W Ball, Meera R Chappidi, et al.
The Prostate
|
June 10, 2023
Prostate cancer genetic alterations in Hispanic men
Camilo Arenas-Gallo, Stephen Rhodes, Jorge A Garcia, et al.
Oncotarget
|
September 9, 2017
Lack of association between the pancreatitis risk allele CEL-HYB and pancreatic cancer
Koji Shindo, Jun Yu, Masaya Suenaga, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
August 22, 2017
High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer
Max Kates, Meera R Chappidi, Aaron Brant, et al.
Gut
|
July 20, 2016
Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms
Jun Yu, Yoshihiko Sadakari, Koji Shindo, et al.
JNCI Cancer Spectrum
|
October 5, 2023
Individual-level home values and cancer mortality in a statewide registry
Alec Zhu, Stephen Rhodes, Weichuan Dong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 8, 2014
KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound
James R Eshleman, Alexis L Norris, Yoshihiko Sadakari, et al.
European Urology Oncology
|
May 26, 2023
Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis
Ilon C Weinstein, Xian Wu, Alexander Hill, et al.
European Urology
|
August 21, 2020
Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Russell E N Becker, Alexa R Meyer, Aaron Brant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2019
Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
Max Kates, Andres Matoso, Woonyoung Choi, et al.
Page
of 6